Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP697821.RANmkNuGZzeJd1lktng9rPQZmKIlE_nqzVcoEcOb4jrFg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP697821.RANmkNuGZzeJd1lktng9rPQZmKIlE_nqzVcoEcOb4jrFg130_assertion type Assertion NP697821.RANmkNuGZzeJd1lktng9rPQZmKIlE_nqzVcoEcOb4jrFg130_head.
- NP697821.RANmkNuGZzeJd1lktng9rPQZmKIlE_nqzVcoEcOb4jrFg130_assertion description "[Overall, identification of metastatic thyroid cancer was better associated with Tg mRNA than with NIS mRNA, sTg, or whole body scan (83% vs. 16.6% vs. 50% vs. 50%; P < 0.001).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP697821.RANmkNuGZzeJd1lktng9rPQZmKIlE_nqzVcoEcOb4jrFg130_provenance.
- NP697821.RANmkNuGZzeJd1lktng9rPQZmKIlE_nqzVcoEcOb4jrFg130_assertion evidence source_evidence_literature NP697821.RANmkNuGZzeJd1lktng9rPQZmKIlE_nqzVcoEcOb4jrFg130_provenance.
- NP697821.RANmkNuGZzeJd1lktng9rPQZmKIlE_nqzVcoEcOb4jrFg130_assertion SIO_000772 11061512 NP697821.RANmkNuGZzeJd1lktng9rPQZmKIlE_nqzVcoEcOb4jrFg130_provenance.
- NP697821.RANmkNuGZzeJd1lktng9rPQZmKIlE_nqzVcoEcOb4jrFg130_assertion wasDerivedFrom befree-20150227 NP697821.RANmkNuGZzeJd1lktng9rPQZmKIlE_nqzVcoEcOb4jrFg130_provenance.
- NP697821.RANmkNuGZzeJd1lktng9rPQZmKIlE_nqzVcoEcOb4jrFg130_assertion wasGeneratedBy ECO_0000203 NP697821.RANmkNuGZzeJd1lktng9rPQZmKIlE_nqzVcoEcOb4jrFg130_provenance.